Home NDC 70710-1716 Sildenafil Citrate
Product NDC 70710-1716
11-digit product format 707101716
Labeler code 70710
Product ID 70710-1716_b42790ec-b9ad-4b34-b98d-dfb8d246eff2
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Sildenafil Citrate
Dosage form POWDER, FOR SUSPENSION
Route ORAL
Labeler Zydus Pharmaceuticals (USA) Inc.
Application ANDA215708
Marketing category ANDA
Marketing start 2022-10-27
Substance SILDENAFIL CITRATE
Active strength 10 mg/mL
Pharmacologic classes Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A215708-001 SILDENAFIL CITRATE SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A215708-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 84e616aacf4f…2026-08-18 06:07:40 2026-07 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 f41ea6bd6efb…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A215708-001 SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL AB 2022-09-29 a50c72e98297…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Sildenafil Citrate
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength SILDENAFIL CITRATE 10 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination BW9B0ZE037 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1307427 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 70710-1716-4 Sildenafil Citrate 112 mL in 1 BOTTLE, GLASS POWDER, FOR SUSPENSION 112 6 70710-1716-4 Sildenafil Citrate 1 in 1 CARTON POWDER, FOR SUSPENSION 1 6 70710-1716-5 Sildenafil Citrate 1 in 1 CARTON POWDER, FOR SUSPENSION 1 6 70710-1716-5 Sildenafil Citrate 112 mL in 1 BOTTLE, PLASTIC POWDER, FOR SUSPENSION 112 6
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 70710-1716 SILDENAFIL CITRATE POWDER, FOR SUSPENSION [ZYDUS PHARMACEUTICALS (USA) INC.] 5 Current NDC, Legacy NDC, 4 package rows 20240328_b2f04ce4-f19c-403d-8a83-74f123e5d30a.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 70710-1716-4 70710171604 1 BOTTLE, GLASS in 1 CARTON (70710-1716-4) / 112 mL in 1 BOTTLE, GLASS 2022-10-27 0000-00-00 No No Current 70710-1716-5 70710171605 1 BOTTLE, PLASTIC in 1 CARTON (70710-1716-5) / 112 mL in 1 BOTTLE, PLASTIC 2022-10-27 0000-00-00 No No Current